209 related articles for article (PubMed ID: 11713795)
1. 2-5A-antisense chimeras: inhibitors of respiratory syncytial virus infection.
Torrence PF
Curr Opin Mol Ther; 1999 Jun; 1(3):307-15. PubMed ID: 11713795
[TBL] [Abstract][Full Text] [Related]
2. The quest for an efficacious antiviral for respiratory syncytial virus.
Torrence PF; Powell LD
Antivir Chem Chemother; 2002 Nov; 13(6):325-44. PubMed ID: 12718405
[TBL] [Abstract][Full Text] [Related]
3. Targeting RNA decay with 2',5' oligoadenylate-antisense in respiratory syncytial virus-infected cells.
Cirino NM; Li G; Xiao W; Torrence PF; Silverman RH
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1937-42. PubMed ID: 9050883
[TBL] [Abstract][Full Text] [Related]
4. 2-5A antisense treatment of respiratory syncytial virus.
Leaman DW
Curr Opin Pharmacol; 2005 Oct; 5(5):502-7. PubMed ID: 16081320
[TBL] [Abstract][Full Text] [Related]
5. Recruiting the 2-5A system for antisense therapeutics.
Torrence PF; Xiao W; Li G; Cramer H; Player MR; Silverman RH
Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):203-6. PubMed ID: 9212911
[No Abstract] [Full Text] [Related]
6. 2-5A-DNA conjugate inhibition of respiratory syncytial virus replication: effects of oligonucleotide structure modifications and RNA target site selection.
Barnard DL; Sidwell RW; Xiao W; Player MR; Adah SA; Torrence PF
Antiviral Res; 1999 Apr; 41(3):119-34. PubMed ID: 10320045
[TBL] [Abstract][Full Text] [Related]
7. Targeted therapy of respiratory syncytial virus in African green monkeys by intranasally administered 2-5A antisense.
Leaman DW; Longano FJ; Okicki JR; Soike KF; Torrence PF; Silverman RH; Cramer H
Virology; 2002 Jan; 292(1):70-7. PubMed ID: 11878909
[TBL] [Abstract][Full Text] [Related]
8. Potent inhibition of respiratory syncytial virus by combination treatment with 2-5A antisense and ribavirin.
Xu Z; Kuang M; Okicki JR; Cramer H; Chaudhary N
Antiviral Res; 2004 Mar; 61(3):195-206. PubMed ID: 15168801
[TBL] [Abstract][Full Text] [Related]
9. (2'-5')Oligoadenylate and intracellular immunity against retrovirus infection.
Schröder HC; Suhadolnik RJ; Pfleiderer W; Charubala R; Müller WE
Int J Biochem; 1992; 24(1):55-63. PubMed ID: 1374726
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of action of interferon.
Baglioni C; Nilsen TW; Maroney PA; de Ferra F
Tex Rep Biol Med; 1981-1982; 41():471-8. PubMed ID: 6189211
[No Abstract] [Full Text] [Related]
11. Potent inhibition of respiratory syncytial virus replication using a 2-5A-antisense chimera targeted to signals within the virus genomic RNA.
Player MR; Barnard DL; Torrence PF
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8874-9. PubMed ID: 9671772
[TBL] [Abstract][Full Text] [Related]
12. [2',5'-A synthetase--gene, enzyme, function].
Sokawa Y
Tanpakushitsu Kakusan Koso; 1992 Oct; 37(14 Suppl):2823-31. PubMed ID: 1279742
[No Abstract] [Full Text] [Related]
13. Chemistry and biochemistry of 2',5'-oligoadenylate-based antisense strategy.
Adah SA; Bayly SF; Cramer H; Silverman RH; Torrence PF
Curr Med Chem; 2001 Aug; 8(10):1189-212. PubMed ID: 11472236
[TBL] [Abstract][Full Text] [Related]
14. The Many Faces of Oligoadenylate Synthetases.
Sarkar SN; Harioudh MK; Shao L; Perez J; Ghosh A
J Interferon Cytokine Res; 2023 Nov; 43(11):487-494. PubMed ID: 37751211
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of antiviral action of interferon.
Baglioni C; Nilsen TW
Interferon; 1983; 5():23-42. PubMed ID: 6202642
[No Abstract] [Full Text] [Related]
16. The Role of Phosphodiesterase 12 (PDE12) as a Negative Regulator of the Innate Immune Response and the Discovery of Antiviral Inhibitors.
Wood ER; Bledsoe R; Chai J; Daka P; Deng H; Ding Y; Harris-Gurley S; Kryn LH; Nartey E; Nichols J; Nolte RT; Prabhu N; Rise C; Sheahan T; Shotwell JB; Smith D; Tai V; Taylor JD; Tomberlin G; Wang L; Wisely B; You S; Xia B; Dickson H
J Biol Chem; 2015 Aug; 290(32):19681-96. PubMed ID: 26055709
[TBL] [Abstract][Full Text] [Related]
17. Interferon-induced enzymes: activation and role in te antiviral state.
Baglioni C; Benvin S; Maroney PA; Minks MA; Nilsen TW; West DK
Ann N Y Acad Sci; 1980; 350():497-509. PubMed ID: 6165300
[No Abstract] [Full Text] [Related]
18. Recurrent Loss-of-Function Mutations Reveal Costs to OAS1 Antiviral Activity in Primates.
Carey CM; Govande AA; Cooper JM; Hartley MK; Kranzusch PJ; Elde NC
Cell Host Microbe; 2019 Feb; 25(2):336-343.e4. PubMed ID: 30713099
[TBL] [Abstract][Full Text] [Related]
19. Comparative studies on (2'-5')oligoadenylate-related enzyme systems and the antiviral effect of interferon in two mouse cell lines which differ in (2'-5')oligoadenylate sensitivity of their protein synthesizing system.
Taira H; Yamamoto F; Furusawa M; Sawai H; Kawakita M
J Interferon Res; 1985; 5(4):583-96. PubMed ID: 2418128
[TBL] [Abstract][Full Text] [Related]
20. A convenient and sensitive fluorescence resonance energy transfer assay for RNase L and 2',5' oligoadenylates.
Thakur CS; Xu Z; Wang Z; Novince Z; Silverman RH
Methods Mol Med; 2005; 116():103-13. PubMed ID: 16000857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
